0.00Open0.00Pre Close0 Volume0 Open Interest24.00Strike Price0.00Turnover223.84%IV-38.81%PremiumDec 20, 2024Expiry Date6.71Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8583Delta0.0481Gamma2.47Leverage Ratio-0.0933Theta-0.0027Rho-2.12Eff Leverage0.0047Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet